Ignelzi Troy A. — SEC insider filings
SEC reporting owner CIK 1579829. 35 insider filings on record with FilingPulse; latest filed 2026-10-21.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2020-08-27 to 2026-10-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 15,500 shares, $244,538 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 44 legs across 17 filings — 135,461 shares, $22,985,915 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 88.
- Largest priced transaction: sale of 16,500 shares @ $227.83 ($3,759,195) in Karuna Therapeutics, Inc., filed 2022-08-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Karuna Therapeutics, Inc. (KRTX) | Chief Financial Officer | 24 | — | 44 legs · 135,461 sh · $22,985,915 | 78 |
| Rapport Therapeutics, Inc. (RAPP) | Chief Financial Officer | 5 | 3 legs · 15,500 sh · $244,538 | — | 3 |
| Contineum Therapeutics, Inc. (CTNM) | Director | 4 | — | — | 4 |
| CinCor Pharma, Inc. (CINC) | Director | 1 | — | — | 2 |
| Harmony Biosciences Holdings, Inc. (HRMY) | Director | 1 | — | — | 1 |
Insider filings — Ignelzi Troy A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-21 | 4 | Rapport Therapeutics, Inc. (RAPP) | Purchase (P): 5,500 @ $26.10 | EDGAR |
| 2026-06-26 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 17,710 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 148,000 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 14,750 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Rapport Therapeutics, Inc. (RAPP) | Purchase (P): 9,900 @ $10.10 · Purchase (P): 100 @ $9.98 | EDGAR |
| 2025-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 142,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 81,366 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 6,350 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 23,150 (derivative) @ $0 | EDGAR |
| 2023-08-24 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 1,500 @ $9.20 · Sale (S): 80 @ $173.64 · Sale (S): 855 @ $174.88 · Sale (S): 505 @ $175.59 · Sale (S): 60 @ $176.60 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 9,000 @ $9.20 · Sale (S): 724 @ $221.28 · Sale (S): 2,093 @ $222.24 · Sale (S): 3,309 @ $223.21 · Sale (S): 1,070 @ $224.19 · Sale (S): 1,022 @ $225.19 · +2 more | EDGAR |
| 2023-02-24 | 4 | CinCor Pharma, Inc. (CINC) | Disposition to issuer (D): 36,324 (derivative) · Disposition to issuer (D): 58,823 (derivative) | EDGAR |
| 2023-02-23 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 6,000 @ $9.20 · Sale (S): 6,000 @ $190.01 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2023-02-13 | 4 | Karuna Therapeutics, Inc. (KRTX) | Grant/award (A): 8,650 @ $0 · Grant/award (A): 17,350 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 817 @ $9.20 · Sale (S): 817 @ $201.41 · Option exercise (M): 200 @ $9.20 · Sale (S): 200 @ $200.14 · Option exercise (M): 817 (derivative) @ $0 · Option exercise (M): 200 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 10,869 @ $9.20 · Option exercise (M): 371 @ $9.20 · Option exercise (M): 627 @ $9.20 · Option exercise (M): 10,869 (derivative) @ $0 · Option exercise (M): 371 (derivative) @ $0 · Option exercise (M): 627 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 16,500 @ $9.20 · Sale (S): 16,500 @ $225.85 · Option exercise (M): 16,500 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | Karuna Therapeutics, Inc. (KRTX) | Sale (S): 2,459 @ $227.05 · Sale (S): 2,819 @ $228.74 · Sale (S): 5,189 @ $229.77 · Sale (S): 33 @ $230.49 · Sale (S): 1,000 @ $230.02 · Sale (S): 2,000 @ $231.30 · +2 more | EDGAR |
| 2022-08-11 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 16,500 @ $9.20 · Sale (S): 16,500 @ $227.83 · Option exercise (M): 16,500 (derivative) @ $0 | EDGAR |
| 2022-04-21 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 3,500 @ $9.20 · Sale (S): 3,500 @ $130.81 · Option exercise (M): 704 @ $9.20 · Sale (S): 704 @ $133.20 · Option exercise (M): 40 @ $9.20 · Sale (S): 40 @ $134.46 · +3 more | EDGAR |
| 2022-02-17 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 1,500 @ $9.20 · Sale (S): 1,500 @ $111.14 · Option exercise (M): 1,500 (derivative) @ $0 · Grant/award (A): 48,500 (derivative) @ $0 | EDGAR |
| 2021-12-22 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 5,869 @ $9.20 · Option exercise (M): 1,101 @ $9.20 · Option exercise (M): 5,869 (derivative) @ $0 · Option exercise (M): 1,101 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 13,500 @ $9.20 · Sale (S): 13,500 @ $152.32 · Option exercise (M): 13,500 (derivative) @ $0 | EDGAR |
| 2021-09-10 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 7,000 @ $9.20 · Sale (S): 7,000 @ $116.16 · Option exercise (M): 600 @ $9.20 · Sale (S): 600 @ $121.01 · Option exercise (M): 500 @ $9.20 · Sale (S): 500 @ $120.05 · +6 more | EDGAR |
| 2021-08-23 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 5,000 @ $9.20 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 2,248 @ $9.20 · Sale (S): 2,248 @ $129.45 · Option exercise (M): 900 @ $9.20 · Sale (S): 900 @ $132.52 · Option exercise (M): 352 @ $9.20 · Sale (S): 352 @ $128.40 · +3 more | EDGAR |
| 2021-05-12 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 7,000 @ $9.20 · Sale (S): 7,000 @ $110.07 · Option exercise (M): 200 @ $9.20 · Sale (S): 200 @ $120 · Option exercise (M): 7,000 (derivative) @ $0 · Option exercise (M): 200 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Karuna Therapeutics, Inc. (KRTX) | Grant/award (A): 51,650 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 10,000 @ $9.20 · Sale (S): 10,000 @ $119.57 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-12 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 8,000 @ $9.20 · Sale (S): 8,000 @ $104.49 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2020-12-29 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 5,869 @ $9.20 · Option exercise (M): 2,131 @ $9.20 · Option exercise (M): 5,869 (derivative) @ $0 · Option exercise (M): 2,131 (derivative) @ $0 | EDGAR |
| 2020-11-10 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 564 @ $9.20 · Sale (S): 564 @ $108.15 · Option exercise (M): 8,000 @ $9.20 · Sale (S): 8,000 @ $105.02 · Option exercise (M): 1,318 @ $9.20 · Sale (S): 1,318 @ $108.26 · +6 more | EDGAR |
| 2020-09-10 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 2,000 @ $9.20 · Sale (S): 2,000 @ $73.30 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2020-08-27 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 5,000 @ $9.20 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579829 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs